Aging of alveolar type 2 cells induced by <i>Lonp1</i> deficiency exacerbates pulmonary fibrosis
Weiwei Zhu(Changchun University of Technology), Jie Zhang(Hebei University of Chinese Medicine), Chunting Tan(University of California San Diego)
Cited by 4
Related Papers
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial
|Signal Transduction and Targeted Therapy|2021|94
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
|Nature Medicine|2025|92
Soluble Thy-1 reverses lung fibrosis via its integrin-binding motif
|JCI Insight|2019|33